Department of Pathology, Faculty of Medicine, Assiut University, Assuit, Egypt.
J Clin Pathol. 2010 Sep;63(9):805-13. doi: 10.1136/jcp.2010.078204.
The possible therapeutic benefits of using steroids to enhance muscle strength and slow disease progression in Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) has been examined previously. In this investigation, it was hypothesised that steroid therapy is associated with morphological changes in the dystrophic muscle.
To test this hypothesis, two muscle biopsies were obtained (one biopsy before treatment, and the second 6 months following prednisone therapy) from 24 patients with dystrophies (18 DMD, 6 BMD). The participants were categorised into: control (6 specimens, normal muscle), untreated and treated groups. The muscle was evaluated for ultrastructural changes using transmission electron microscopy (TEM).
In the untreated group, the muscle fibres were degenerated and of variable sizes. The myofibrils were thin with either complete loss of bands and/or abnormal banding patterns. The Z-lines were irregularly spaced and loosely registered. The mitochondria of the myofibrils were small, few, spherical and irregularly distributed. Numerous dendritic cells (DCs) with euchromatic nuclei, and multiple and long dendrites, were seen among the myofibrils. The collagen fibres among the muscle fibres (endomysium) were numerous and large. The satellite cells had euchromatic nuclei with clumps of heterochromatin. In the treated group, the muscle fibres had a relatively uniform size with occasional fibres showing partial degeneration. The myofibrils had a relatively similar diameter comparable to that of normal muscle .The degenerated areas were small in size with occasional foci showing loss of banding pattern, and abnormal short bands with thick and hazy Z-lines. The mitochondria of the myofibrils were numerous, spherical, small in size and regularly arranged between the myofibrils. Few DCs, with heterochromatic nuclei, and few and short dendrites appeared between the myofibrils. The collagen fibres between the muscle fibres (endomysium) were numerous and large. As compared with the treated group, there was a statistically significant increase (p<0.05) in the numbers of DCs (0.7+/-0.2 vs 1.6+/-0.3) and fibroblasts (1.9+/-0.2 vs 2.9 +/-0.3) in the untreated group. Alternatively, there was a statistically significant decrease (p<0.05) in the numbers of satellite cells (1.2+/-0.2 vs 0.6+/-0.1).
The ability of steroids to induce ultrastructural features of improvement supports the notion that they have beneficial therapeutic role. The clinical ramifications of these observations mandate further studies.
此前曾研究过使用类固醇来增强肌肉力量并减缓杜兴氏肌营养不良症(DMD)和贝克肌营养不良症(BMD)疾病进展的可能治疗益处。在这项研究中,假设类固醇治疗与营养不良肌肉的形态变化有关。
为了验证这一假设,从 24 名患有肌营养不良症的患者中获得了(治疗前 1 次活检,治疗后 6 个月 2 次活检)两次肌肉活检(18 名 DMD,6 名 BMD)。将参与者分为对照组(6 个标本,正常肌肉)、未治疗组和治疗组。使用透射电子显微镜(TEM)评估肌肉的超微结构变化。
在未治疗组中,肌纤维退化,大小不一。肌原纤维很细,带有完整的带缺失和/或异常带型。Z 线不规则间隔,注册松散。肌原纤维的线粒体小、少、球形且分布不规则。肌原纤维之间可见许多具有常染色质核和多个长树突的树突状细胞(DC)。肌肉纤维之间的胶原纤维(肌内膜)数量众多且粗大。卫星细胞的常染色质核有染色质团块。在治疗组中,肌纤维大小相对均匀,偶尔有纤维显示部分退化。肌原纤维的直径相对相似,与正常肌肉相似。退化区域的大小较小,偶尔出现带型缺失的焦点和异常的短带,以及带厚而模糊的 Z 线。肌原纤维的线粒体数量众多,呈球形,大小较小,排列在肌原纤维之间。肌原纤维之间出现少数具有异染色质核和少数短树突的 DC。肌纤维之间的胶原纤维(肌内膜)数量众多且粗大。与治疗组相比,未治疗组的 DC(0.7+/-0.2 对 1.6+/-0.3)和成纤维细胞(1.9+/-0.2 对 2.9 +/-0.3)的数量显著增加(p<0.05)。或者,卫星细胞(1.2+/-0.2 对 0.6+/-0.1)的数量显著减少(p<0.05)。
类固醇诱导超微结构改善的能力支持它们具有有益的治疗作用的观点。这些观察结果的临床意义需要进一步研究。